Increase in the Prevalence of Atrophic Gastritis Among Adults Age 35 to 44 Years Old in Northern Sweden Between 1990 and 2009

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 9, 2015, Pages 1592-1600.e1

  Song, Huan ^a   Held, Maria ^b   Sandin, Sven ^a   Rautelin, Hilpi ^c,d   Eliasson, Mats ^e   Söderberg, Stefan ^e   Hallmans, Göran ^e   Engstrand, Lars ^a   Nyrén, Olof ^a   Ye, Weimin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Hallands Sjukhus Halmstad ^*  (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF HELSINKI   (Finland)

^e UMEÅ UNIVERSITY   (Sweden)

Author keywords

BMI; MONICA Study; Secular Trend; Stomach

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; CAG PATHOGENICITY ISLAND PROTEIN A; PEPSINOGEN I; UNCLASSIFIED DRUG; PEPSINOGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; ATROPHIC CORPUS GASTRITIS; ATROPHIC GASTRITIS; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; EDUCATIONAL STATUS; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; QUESTIONNAIRE; RISK ASSESSMENT; SEROPREVALENCE; SWEDEN; TREND STUDY; AGE; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; GASTRITIS, ATROPHIC; MIDDLE AGED; RISK FACTOR;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GASTRITIS, ATROPHIC; HUMANS; MALE; MIDDLE AGED; PEPSINOGEN A; PREVALENCE; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; SWEDEN;

EID: 84939574046     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.04.001     Document Type: Article

References (25)

1. Cancer Incidence in Sweden 2011 2013, The National Board of Health and Welfare, Stockholm.
2. Anderson W.F., Camargo M.C., Fraumeni J.F., et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 2010, 303:1723-1728.
3. de Vries A.C., van Grieken N.C., Looman C.W., et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008, 134:945-952.
4. Sipponen P., Helske T., Jarvinen P., et al. Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992. Gut 1994, 35:1167-1171.
5. de Vries A.C., Meijer G.A., Looman C.W., et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut 2007, 56:1665-1670.
6. Agreus L., Kuipers E.J., Kupcinskas L., et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand J Gastroenterol 2012, 47:136-147.
7. Adamu M.A., Weck M.N., Gao L., et al. Incidence of chronic atrophic gastritis: systematic review and meta-analysis of follow-up studies. Eur J Epidemiol 2010, 25:439-448.
8. Stegmayr B., Lundberg V., Asplund K. The events registration and survey procedures in the Northern Sweden MONICA Project. Scand J Public Health Suppl 2003, 61:9-17.
9. Oksanen A., Sipponen P., Karttunen R., et al. Atrophic gastritis and Helicobacter pylori infection in outpatients referred for gastroscopy. Gut 2000, 46:460-463.
10. Storskrubb T., Aro P., Ronkainen J., et al. Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: the Kalixanda study. Scand J Gastroenterol 2008, 43:1448-1455.
11. Monteiro L., de Mascarel A., Sarrasqueta A.M., et al. Diagnosis of Helicobacter pylori infection: noninvasive methods compared to invasive methods and evaluation of two new tests. Am J Gastroenterol 2001, 96:353-358.
12. Siman J.H., Engstrand L., Berglund G., et al. Evaluation of western blot CagA seropositivity in Helicobacter pylori-seropositive and -seronegative subjects. Clin Diagn Lab Immunol 2005, 12:304-309.
13. Di Mario F., Germana B., Vianello F., et al. Smoking habit enhanced pepsinogen group I in healthy subjects. Gastroenterology 1991, 100:288-289.
14. Cancer incidence in five continents. Vol X (electronic version) 2013, IARC, Lyon, Available:, Accessed: May12, 2014. http://ci5.iarc.fr, B.F. Forman, D.H. Brewster, C. Gombe Mbalawa (Eds.).
15. Weck M.N., Brenner H. Prevalence of chronic atrophic gastritis in different parts of the world. Cancer Epidemiol Biomarkers Prev 2006, 15:1083-1094.
16. Joo Y.E., Park H.K., Myung D.S., et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver 2013, 7:303-310.
17. Rodgers A., Macmahon S. Systematic underestimation of treatment effects as a result of diagnostic-test inaccuracy - implications for the interpretation and design of thromboprophylaxis trials. Thromb Haemost 1995, 73:167-171.
18. Koivisto T.T., Voutilainen M.E., Farkkila M.A. Effect of smoking on gastric histology in Helicobacter pylori-positive gastritis. Scand J Gastroenterol 2008, 43:1177-1183.
19. Nakamura M., Haruma K., Kamada T., et al. Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects. Dig Dis Sci 2002, 47:675-681.
20. Plummer M., van Doorn L.J., Franceschi S., et al. Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. J Natl Cancer Inst 2007, 99:1328-1334.
21. Kutsuma A., Oshida H., Suwa K., et al. A possible association of low pepsinogen I and pepsinogen I/II with low and high body weight in Japanese men. Clin Biochem 2014, 47:126-128.
22. Kim H.J., Kim N., Kim H.Y., et al. Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection. Gastric Cancer 2014, Epub ahead of print.
23. Yamamoto S., Watabe K., Takehara T. Is obesity a new risk factor for gastritis?. Digestion 2012, 85:108-110.
24. Lilja M., Eliasson M., Stegmayr B., et al. Trends in obesity and its distribution: data from the Northern Sweden MONICA Survey, 1986-2004. Obesity (Silver Spring) 2008, 16:1120-1128.
25. Hansson L.E., Baron J., Nyren O., et al. Early-life risk indicators of gastric-cancer - a population-based case-control study in Sweden. Int J Cancer 1994, 57:32-37.